Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014

Details for Mechanism ID: 14538
Country/Region: Tanzania
Year: 2012
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $500,000

In the second year of this mechanism, ICAP will continue to build on its extensive experience partnering with government agencies and community-based organizations in Tanzania to support URTs efforts to ensure a unified response to TB/HIV co-infection in the pediatric population. To achieve a sustainable response, ICAP will intensify the work initiated in enhancing the stewardship and capacity of MOHSW towards an effective national response to TB/HIV co-infections among children. Furthermore, the newly established pediatric TB/HIV Center of Excellence (COE) at Mwananyamala Hospital in Dar es Salaam will serve as a resource centre to healthcare workers. Trainings will be augmented by on-going mentorship in diagnostic procedures through clinical attachments at the COE, as well as on-site mentorship and supportive supervision from ICAP. Pediatric TB diagnostic algorithms and standard operating procedures will be strengthened to ensure that all TB suspects undergo a diagnostic work up, including chest x-ray and gene Xpert investigations, where indicated.

During the second through fifth years, ICAP will support scale-up and expansion of pediatric TB/HIV services through formation of regional COEs and establishment of linkages and referral systems with a network of private and public-sector satellite health facilities in regions with high TB and HIV burdens. ICAP will mentor regional and council health management teams so that they can ultimately assume management responsibilities and can sustain and ensure achievements beyond the life of the project. Support to MKUTA (NGO of former TB clients) to provide health education and contact tracing at community levels will continue with establishment of more TB clubs.

Funding for Treatment: Pediatric Treatment (PDTX): $500,000

Building on its highly effective working relationship with the NTLP and NACP, ICAP will engage MOHSW and provide support to strategically plan, manage, and evaluate pediatric TB/HIV diagnostics, prevention/control, and care and treatment programs. ICAP will facilitate stakeholders meetings which will be coordinated and conducted by NTLP and NACP to foster an enabling, collaborative environment and ensure a unified response to pediatric TB/HIV among MOHSW and implementing partners. ICAP will also actively participate and engage in the TWG and planning bodies to support the review and revision of existing pediatric TB/HIV guidelines, training curricula, and national policy related to TB/HIV to reflect the latest WHO guidelines.

As a means of strengthening the workforce at the MOHSW-NTLP unit, ICAP will hire a pediatrician and a nursing officer who will coordinate pediatric TB/HIV activities. ICAP will conduct a training of trainers for pediatric TB/HIV and provide TA to develop a TB screening tool for children under six, based on ICAPs evidence-based pediatric TB/HIV screening approaches in other African countries.

ICAP will support MOHSW to conduct a systematic review of its TB and HIV recording tools to ensure that patients forms and registers are streamlined and their clinical information accommodates the pediatric TB/HIV programs M&E. ICAP will work in strengthening TB screening and diagnosis outcomes as well as linkages to care and treatment for HIV and TB in children. ICAP will also support the regular review of pediatric TB/HIV data to inform program evaluation and planning.

In collaboration with the RHMT of Dar es Salaam City Council and the CHMT of Kinondoni Municipality, ICAP will strengthen activities at the pediatric TB/HIV COE at Mwananyamala Hospital for the provision of comprehensive services for children with TB/HIV co-infection. Collaboration with the Kinondoni Municipal Council and existing partners at Mwananyamala Hospital, including Management and Development for Health (MDH) and PATH, that provide support to Mwananyamala Hospitals care and treatment and TB programs, respectively will be enhanced to ensure ownership. The activities include infrastructure support, provision of trainings for staff followed by strong clinical mentorship support at the COE and strengthening of the M&E system for program evaluation and continuous quality improvement of the pediatric TB/HIV COE.

ICAP will collaborate with MOHSW and Kinondoni Municipality CHMT on rapid laboratory infrastructure and staff capacity assessments to establish a lab network between the COE TB laboratory and lab network within the Kinondoni Municipality. During the second through fifth years, ICAP will support scale-up and expansion of pediatric TB/HIV services through formation of regional COE and establishment of linkages and referral systems with a network of private and public-sector satellite health facilities. Healthcare workers will be trained by national trainers and will receive mentorship in diagnostic procedures and clinical skills through clinical attachments at the COE as well as on-site mentorship and supportive supervision from ICAP.

Key Issues Identified in Mechanism
Tuberculosis